Bellicum Pharmaceuticals, Inc. (BLCM) Stock Analysis
DELISTED 2024
What happened to Bellicum Pharmaceuticals, Inc. (BLCM) stock?
Bellicum Pharmaceuticals, Inc. (BLCM) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2024
- Last recorded price (historical):
- $0.0748 (last quote on record before the March 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Bellicum Pharmaceuticals, Inc. (BLCM). Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel cellular immunotherapies for hematological cancers and solid tumors.
Last analyzed: Jun 14, 2026Bellicum Pharmaceuticals, Inc. (BLCM) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BLCM shares?
No. BLCM stopped trading on public markets in March 2024, so the shares are not available through a broker. Anything you see quoted for BLCM elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BLCM stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Bellicum Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.